Could a drug make milk allergy therapy safer and more effective?
NCT ID NCT04148352
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding dupilumab (a drug that reduces allergic reactions) to milk oral immunotherapy (gradually eating small amounts of milk) helps people with cow's milk allergy tolerate more milk with fewer side effects. The trial included 33 people aged 4 to 50 years. The study was stopped early, so results are limited, but the goal was to see if the combination allowed participants to safely consume at least 2040 mg of milk protein.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIES FOOD MILK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Scottsdale, Arizona, 85259, United States
-
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
-
Sean N. Parker Center for Allergy & Asthma Research at Stanford University
Palo Alto, California, 94304, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could supermarket peanuts and milk cure food allergies? new study investigates.
- New formula could offer safe option for Milk-Allergic babies
- Fast vs. slow: which oral allergy treatment works best for kids?
- New study aims to unlock secrets of food allergy tolerance in kids
- Food allergy treatment: how do kids fare years later?
- Blood test may tell if kids have outgrown food allergies